Published in N Engl J Med on April 15, 1971
Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest (1980) 1.51
Long-term management of abetalipoproteinaemia. Possible role for vitamin E. Arch Dis Child (1977) 1.44
Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia. J Clin Invest (1972) 1.13
Insulin effects on apolipoprotein B production by normal, diabetic and treated-diabetic rat liver and cultured rat hepatocytes. Biochem J (1989) 1.11
Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypolphalipoproteinemia and fasting chylomicronemia. J Clin Invest (1979) 1.08
Lymph chylomicron formation during the inhibition of protein synthesis. Studies of chylomicron apoproteins. J Clin Invest (1973) 1.07
Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinaemia. Br J Ophthalmol (1982) 1.01
A study of the abnormal lipoproteins in abetalipoproteinemia. J Clin Invest (1974) 1.00
Effects of nonketotic streptozotocin diabetes on apolipoprotein B synthesis and secretion by primary cultures of rat hepatocytes. J Clin Invest (1988) 0.98
Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia. Br J Ophthalmol (1986) 0.94
Fat absorption during inhibition of protein synthesis: studies of lymph chylomicrons. J Clin Invest (1972) 0.93
Vitamin E--its role in neurological function. Postgrad Med J (1986) 0.91
The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption. J Inherit Metab Dis (1985) 0.87
Ocular findings in a form of retinitis pigmentosa with a rhodopsin gene defect. Trans Am Ophthalmol Soc (1990) 0.86
Impaired hepatic apolipoprotein B and E translation in streptozotocin diabetic rats. J Clin Invest (1992) 0.85
Chemical and kinetic study of the lipoproteins in abetalipoproteinaemic plasma. J Clin Pathol (1978) 0.77
Inhibition of apolipoprotein B net synthesis and secretion from cultured rat hepatocytes by the calcium-channel blocker diltiazem. Biochem J (1989) 0.76
Hypolipoproteinaemia. J Clin Pathol Suppl (Assoc Clin Pathol) (1973) 0.75
Inherited disorders of serum lipoproteins. Proc R Soc Med (1971) 0.75
A comparaive study of the effects of chemical modification on the immunochemical and optical properties of human plasma low-density lipoprotein(s) and apoproteins. Biochem J (1973) 0.75
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta (1972) 9.02
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med (2001) 7.51
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 6.51
Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ (1970) 5.58
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation (1997) 4.41
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 4.09
The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest (1972) 3.43
A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett (1974) 3.43
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation (1974) 3.29
Serum cholesterol. Doing the right thing. Circulation (1993) 3.16
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA (1994) 3.11
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 3.09
Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem (1969) 2.98
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 2.86
Binding of long-chain fatty acids to bovine serum albumin. J Lipid Res (1969) 2.63
Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. Circulation (1984) 2.41
The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae. Proc Natl Acad Sci U S A (1966) 2.32
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb (1992) 2.31
Pathogenesis and management of lipoprotein disorders. N Engl J Med (1985) 2.31
A specific apoprotein activator for lipoprotein lipase. Biochem Biophys Res Commun (1970) 2.24
Digital imaging fluorescence microscopy: spatial heterogeneity of photobleaching rate constants in individual cells. J Cell Biol (1985) 2.20
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation (1986) 2.06
Lipoprotein structure and metabolism. Physiol Rev (1976) 2.04
Lipoprotein metabolism. Adv Lipid Res (1975) 1.90
Children of depressed parents. Increased psychopathology and early onset of major depression. Arch Gen Psychiatry (1987) 1.88
Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry (1973) 1.81
Total inhibition of hepatic beta-lipoprotein production in the rat by orotic acid. J Biol Chem (1967) 1.79
Lipoproteins: structure and function. Annu Rev Biochem (1975) 1.76
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res (2001) 1.74
Relation of diet to high-density-lipoprotein cholesterol in middle-aged marathon runners, joggers, and inactive men. N Engl J Med (1980) 1.72
Introduction to the plasma lipoproteins. Methods Enzymol (1986) 1.71
Declining mortality in coronary heart disease. Arteriosclerosis (1982) 1.70
Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. J Clin Invest (1978) 1.69
Human plasma lipoprotein [a]. Structural properties. J Biol Chem (1983) 1.68
Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J Clin Invest (1974) 1.66
Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. Biochemistry (1975) 1.66
Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb (1993) 1.65
Limitations of the electrocardiographic response to exercise in predicting coronary-artery disease. N Engl J Med (1975) 1.61
Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method. Clin Chem (1989) 1.60
On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. Biochim Biophys Acta (1973) 1.59
Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res (2000) 1.57
The plasma lipoproteins: structure and metabolism. Annu Rev Biochem (1978) 1.54
A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques. J Clin Invest (1969) 1.54
The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. Circulation (1984) 1.54
High density lipoprotein metabolism in man. J Clin Invest (1977) 1.53
Progress in prevention of cardiovascular disease. Prev Med (1978) 1.53
Health family trees: a tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. Am J Public Health (1988) 1.53
Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A (1978) 1.53
Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects. J Lipid Res (1978) 1.53
Cardiovascular pathology in hyperlipoproteinemia. Anatomic observations in 42 necropsy patients with normal or abnormal serum lipoprotein patterns. Am J Cardiol (1973) 1.52
AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. J Am Coll Cardiol (1995) 1.52
The primary structure of human apolipoprotein A-IV. Biochim Biophys Acta (1989) 1.50
Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest (1974) 1.50
The nature of pre beta (very low density) lipoproteins. J Clin Invest (1966) 1.48
Lipoprotein apoprotein metabolism. J Lipid Res (1978) 1.48
The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol (2000) 1.46
Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease. Am J Cardiol (1969) 1.45
Plasma lipid and lipoprotein response of humans to beef fat, coconut oil and safflower oil. Am J Clin Nutr (1985) 1.45
Production of beta-lipoprotein by intestine in the rat. J Biol Chem (1968) 1.45
Comparison of the triglyceride lipase of liver, adipose tissue, and postheparin plasma. J Lipid Res (1972) 1.44
Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc Natl Acad Sci U S A (1999) 1.42
Risk reduction. Circulation (2000) 1.42
Communication patterns in a biomedical research center. J Med Educ (1978) 1.42
Current therapy for hypercholesterolemia. JAMA (1989) 1.42
The assessment of social adjustment. An update. Arch Gen Psychiatry (1981) 1.42
An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction. Am J Cardiol (1991) 1.42
A prospective study of genetic markers of susceptibility to infection and inflammation, and the severity, progression, and regression of coronary atherosclerosis and its response to therapy. J Mol Med (Berl) (2000) 1.42
Kinetics of lipid--protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. Biochemistry (1978) 1.41
Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA (1989) 1.40
Acute muscular syndrome associated with administration of clofibrate. N Engl J Med (1968) 1.40
The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects. J Infect Dis (1998) 1.40
Parent and child reports of depressive symptoms in children at low and high risk of depression. J Child Psychol Psychiatry (1987) 1.40
The cyanogen bromide peptides of the apoprotein of low density lipoprotein (ApoB): its molecular weight from a chemical view. Biochem Biophys Res Commun (1978) 1.39
The complete cDNA and amino acid sequence of human apolipoprotein B-100. J Biol Chem (1986) 1.39
The Social Adjustment Inventory for Children and Adolescents (SAICA): testing of a new semistructured interview. J Am Acad Child Adolesc Psychiatry (1987) 1.38
Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man. J Clin Invest (1968) 1.38
Preventing heart attack and death in patients with coronary disease. Circulation (1995) 1.36
Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A (1983) 1.36
The human apolipoprotein B-100 gene: a highly polymorphic gene that maps to the short arm of chromosome 2. Biochem Biophys Res Commun (1985) 1.36
Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100. Proc Natl Acad Sci U S A (1985) 1.35
Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. Proc Natl Acad Sci U S A (1977) 1.35